Published on 22 Jul 2023 on Simply Wall St. via Yahoo Finance
One Fate Therapeutics Insider Raised Stake By 83% In Previous Year
Viewing insider transactions for Fate Therapeutics, Inc.'s (NASDAQ:FATE ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.
View our latest analysis for Fate Therapeutics